The Magnitude of MTB and Rifampicin Resistance MTB Using Xpert-MTB/RIF Assay Among Tuberculosis Suspected Patients in Gedeo Zone, Southern Ethiopia.

Kuma DiribaEphrem AwulachewGemechu Churiso

Published in: Infection and drug resistance (2021)

A high magnitude of MTB and RR-MTB was reported among TB patients with HIV and a history of previous treatment. Therefore, coordinated efforts should be applied to the improvement of treatment adherence of known TB cases, and appropriate control and prevention methods to reduce the emergence and increase of MTB and RR-MTB cases.

Keyphrases

mycobacterium tuberculosis
pulmonary tuberculosis
human immunodeficiency virus
ejection fraction
metabolic syndrome
hiv positive
high throughput
antiretroviral therapy
hiv infected
quality improvement
electronic health record
south africa
patient reported